RENEO PHARMACEUTICALS

reneo-pharmaceuticals-logo

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases. It focuses on the development of treatments for genetic disorders associated with defects in energy metabolism resulting in myopathy that enable caregivers to improve the daily function and quality of life of patients suffering from these diseases by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness, and wasting. The company was founded in 2014 and is headquartered in San Diego, California.

#SimilarOrganizations #People #Financial #Event #Website #More

RENEO PHARMACEUTICALS

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2014-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.reneopharma.com

Total Employee:
11+

Status:
Active

Contact:
+1 858-283-0280

Total Funding:
145 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

lon-cardon_image

Lon Cardon Member, Board of Directors @ Reneo Pharmaceuticals
Board_member

ed-mathers_image

Ed Mathers Member, Board of Directors @ Reneo Pharmaceuticals
Board_member

johan-kördel_image

Johan Kördel Member, Board of Directors @ Reneo Pharmaceuticals
Board_member

Current Employees Featured

niall-odonnell_image

Niall O&s;Donnell
Niall O'Donnell Co-Founder, President, and CEO @ Reneo Pharmaceuticals
Co-Founder, President, and CEO

alejandro-dorenbaum_image

Alejandro Dorenbaum
Alejandro Dorenbaum Chief Medical Officer @ Reneo Pharmaceuticals
Chief Medical Officer

not_available_image

Wendy Newman
Wendy Newman Head, Patient Engagement and Communications @ Reneo Pharmaceuticals
Head, Patient Engagement and Communications

not_available_image

Vinny Jindal
Vinny Jindal Chief Financial Officer @ Reneo Pharmaceuticals
Chief Financial Officer
2021-03-01

gregory-flesher_image

Gregory Flesher
Gregory Flesher President and CEO @ Reneo Pharmaceuticals
President and CEO
2020-11-01

ashley-hall_image

Ashley Hall
Ashley Hall Chief Development Officer @ Reneo Pharmaceuticals
Chief Development Officer
2021-10-01

wendy-s-johnson_image

Wendy S. Johnson
Wendy S. Johnson Chief Operating Officer @ Reneo Pharmaceuticals
Chief Operating Officer

Founder


michael-grey_image

Michael Grey

niall-odonnell_image

Niall O'Donnell

Stock Details


Company's stock symbol is NASDAQ:RPHM

Investors List

pappas-capital_image

Pappas Capital

Pappas Capital investment in Series B - Reneo Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - Reneo Pharmaceuticals

lundbeckfond-ventures_image

Lundbeckfonden Ventures

Lundbeckfonden Ventures investment in Series B - Reneo Pharmaceuticals

abingworth-management_image

Abingworth

Abingworth investment in Series B - Reneo Pharmaceuticals

amzak-health-investors_image

Amzak Health Investors

Amzak Health Investors investment in Series B - Reneo Pharmaceuticals

chiesi-ventures_image

Chiesi Ventures

Chiesi Ventures investment in Series B - Reneo Pharmaceuticals

rivervest_image

RiverVest

RiverVest investment in Series B - Reneo Pharmaceuticals

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series B - Reneo Pharmaceuticals

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series B - Reneo Pharmaceuticals

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series B - Reneo Pharmaceuticals

Key Employee Changes

Date New article
2021-10-11 Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer

Official Site Inspections

http://www.reneopharma.com Semrush global rank: 2.4 M Semrush visits lastest month: 7.62 K

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 3.33.251.168
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Reneo Pharmaceuticals"

Reneo Pharmaceuticals - Crunchbase Company Profile & Funding

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases. It focuses on the development of treatments for …See details»

Reneo Pharmaceuticals - Craft

Oct 4, 2024 Reneo Pharmaceuticals is a pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. It develops REN001, a selective …See details»

Reneo Pharmaceuticals Company Overview, Contact Details

May 3, 2023 JDoe@reneopharma.com: 100%. See more formats. Frequently Asked Questions Where is Reneo Pharmaceuticals 's headquarters located? Reneo Pharmaceuticals 's main …See details»

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

May 13, 2024 Management and Organization. Following the merger, the combined company will be led by Nicholas Saccomano, Ph.D., President and Chief Executive Officer of OnKure, and …See details»

Reneo Pharmaceuticals - Overview, News & Similar companies

May 7, 2024 Reneo Pharmaceuticals contact info: Phone number: (858) 283-0280 Website: www.reneopharma.com What does Reneo Pharmaceuticals do? Reneo Pharmaceuticals is a …See details»

Reneo Pharmaceuticals, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Reneo Pharmaceuticals, Inc. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.See details»

Reneo Pharmaceuticals, Inc. (RPHM) - Yahoo Finance Canada

See the company profile for Reneo Pharmaceuticals, Inc. (RPHM) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»

Org Chart Reneo Pharmaceuticals - The Official Board

The organizational chart of Reneo Pharmaceuticals displays its 15 main executives including Gregory Flesher, Michael Cruse and Wendy JohnsonSee details»

Reneo Pharmaceuticals Management Team | Org Chart

Reneopharma.com; 1 949292XXXX; View Similar People. Related Companies GeneTex, Inc. 42 $26.6m Biomerica, Inc. 54 $14.6m Oncocyte Corporation. 84 $9m Zymo Research Corp. 193 …See details»

Reneo Pharmaceuticals - Pappas Capital

Reneo Pharmaceuticals is a clinical-stage start-up company, co-founded by Pappas Capital, focused on developing treatments for rare metabolic disordersSee details»

Reneo Pharmaceuticals - Company Profile & Staff Directory

Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with …See details»

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

May 13, 2024 Management and Organization. Following the merger, the combined company will be led by Nicholas Saccomano, Ph.D., President and Chief Executive Officer of OnKure, and …See details»

Reneo Pharmaceuticals - PitchBook

Reneo Pharmaceuticals General Information Description. Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with …See details»

Reneo Pharma - VentureRadar

The company will build a fully integrated research, development, and commercial organization, developing innovative therapeutics and taking them directly to the patients. Stealth …See details»

Reneo Pharmaceuticals to Participate in Upcoming Investor

IRVINE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the...See details»

Reneo Pharma - VentureRadar

Website: https://reneopharma.com/ Develops therapies for genetic mitochondrial diseases, focusing on improving mitochondrial function, preserving muscle function, and ...See details»

Reneo Pharmaceuticals Announces Stockholder Approval of …

Oct 3, 2024 Investor Relations Reneo Pharmaceuticals, Inc. investors@reneopharma.com Investor Relations OnKure, Inc. Dan Ferry LifeSci Advisors daniel@lifesciadvisors.com …See details»

Reneo Pharmaceuticals Announces Stockholder Approval of …

Oct 3, 2024 On September 26, 2024, Reneo stockholders approved the reverse stock split and gave Reneo’s board of directors discretionary authority to select a ratio for the reverse stock …See details»

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

May 13, 2024 Management and Organization Following the merger, the combined company will be led by Nicholas Saccomano , Ph.D., President and Chief Executive Officer of OnKure, and …See details»

Reneo Pharmaceuticals Announces Changes to its Board of Directors

IRVINE, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and …See details»

linkstock.net © 2022. All rights reserved